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Background: Rhinoviruses (RVs) are ubiquitous pathogens and the principal etiological 
agents of common cold. Despite the high frequency of RV infections, data describing their 
long-term epidemiological patterns in a defined population remain limited.  
Methods: Here, we analysed 1,070 VP4/VP2 genomic region sequences sampled at Kilifi 
County Hospital on the Kenya Coast. The samples were collected between 2007 and 2018 
from hospitalised paediatric patients (< 60 months) with acute respiratory illness.  
Results: Of 7,231 children enrolled, RV was detected in 1,497 (20.7%) and VP4/VP2 
sequences were recovered from 1,070 samples (71.5%). A total of 144 different RV types 
were identified (67 Rhinovirus A, 18 Rhinovirus B and 59 Rhinovirus C) and at any month, 
several types co-circulated with alternating predominance. Within types multiple genetically 
divergent variants were observed. Ongoing RV infectio s through time appeared to be a 
combination of (i) persistent types (observed up to seven consecutive months), (ii) 
reintroduced genetically distinct variants and (iii) new invasions (average of eight new types, 
annually).  
Conclusion: Sustained RV presence in the Kilifi community is mainly due to frequent 
invasion by new types and variants rather than continuous transmission of locally 
established types/variants.  
 





















Rhinovirus (RVs) are a highly prevalent group of viruses and are the principal cause of 
common cold syndrome in humans globally 1,2. RV infections result in a wide range of clinical 
outcomes spanning from asymptomatic and mild illness in the upper airways to severe 
illness in the lower airways 3,4. The infections occur in all ages, with severe presentation 
more likely in children under the age of 5 years 5,6, the elderly 7 and immunocompromised 8. 
Despite the clinical significance of RV infections, there is little information on the long-term 
trends and diversity of circulating RV types.  
RV belongs to the genus Enterovirus of the family Picornaviridae. The viral single-
stranded positive sense RNA genome consists of ~7200 nucleotides and encodes four 
structural proteins (VP4, VP2, VP3 and VP1) and seven non-structural proteins (2A, 2B, 2C, 
3A, 3B, 3C and 3D) 2. The three surface-exposed capsid proteins (VP1, VP2 and VP3) carry 
the antigenically critical sites 9–11. The high genetic variability in the VP4/VP2 and VP1 
genomic regions of rhinoviruses have been instrumental in molecular typing 12,13 and 
molecular epidemiological investigations of rhinovirus infections 14–16. Currently, a total of 
169 RV types have been described, and classified into three species i.e., Rhinovirus A, 
Rhinovirus B and Rhinovirus C 
(https://www.picornaviridae.com/sg3_ensavirinae/enterovirus/enterovirus.htm).  
RV infections occur all year-round in most geographical locations, although peaking 
in the early autumn and late spring in many temperate countries, and in the rainy season in 
tropical countries 2,17. Unclear seasonality and year-round transmission of rhinoviruses have 
been attributed to lack of inter-type cross-protective immunity 18,19, coupled with the high 
genetic diversity within the three species, each with the ability to spread independently in a 
population 16,20,21. 
A recent study in Kilifi county located in coastal Kenya, that span over 12-month 



















varied time periods ranging from 1 to 9 months and in most cases, each displaying a typical 
epidemic curve at the local population level; transmission presumably constrained by the 
decline in susceptibles to that type within the locality. Type-specific (homologous) immunity 
has been reported to wane approximately after a one-year period 22, and individuals who 
were previously immune to a particular type gradually become susceptible to the type again 
22,23. Previous studies found that introduction of new RV types or sequential invasion by 
different genetic variants could be due to declining levels of population immunity as well as 
viral evolution 24,25. 
These assertions of perpetually changing RV types during year-round RV 
transmission have not been fully investigated in a longitudinal manner 16. In this study, we 
analyzed VP4/VP2 sequences of samples collected from hospitalized children with acute 
respiratory illness (ARI) between 2007 and 2018 on the Kenyan Coast to evaluate the long-
term incidence of the different RV types, their temporal patterns and intensity of new 
invasions in a local population.  
 
Methods 
Study area and population  
The study was conducted at the Kilifi County Hospital (KCH) as part of long-term 
surveillance initially aimed at understanding the epidemiology and disease burden of 
respiratory syncytial virus (RSV)-associated pneumonia cases 26 and expanded to a range of 
respiratory viruses from 2007 27–32. KCH, located on the coast of Kenya, is a referral hospital 
serving the wider Kilifi County which has a population of 1,453,787 and covers an area of 
~12,254 square km. Details of study design, participant recruitment, and sampling 
procedures have been described elsewhere 26,32. Briefly, upon presentation to the paediatric 
ward, a detailed medical review was undertaken by the clinician and the decision to admit 



















between January 2007 and December 2018 were eligible if they presented with symptoms of 
syndromic severe or very severe pneumonia. Clinical definitions include: a history of cough 
or difficulty in breathing for less than 30 days, which if accompanied by lower chest wall 
indrawing was defined as severe pneumonia; or if accompanied by any one of prostration, 
coma or hypoxemia was defined as very severe pneumonia; prostration including the 
inability to feed or drink, and hypoxemia defined by oxygen saturation (pO2) <90% 
26. 
Following a written informed consent from the parent or guardian, a nasopharyngeal flocked 
swab, nasal wash or combination of nasopharyngeal swab and oropharyngeal swab was 
collected from each child and transferred into viral transport medium for laboratory 
screening. Ethical approval for the study protocol was obtained from the Scientific and Ethics 
Review Unit (SERU # 3443) ethics committee, Kenya Medical Research Institute, Nairobi, 
Kenya. 
 
RV screening and sequencing  
Viral RNA was extracted from each sample using QIAamp Viral RNA kit (Qiagen Inc., 
Valencia, California, USA) and screened for respiratory viruses using a multiplex real-time 
reverse-transcription PCR (rt-RT-PCR) (Applied Biosystems, United Kingdom) as described 
elsewhere 33,34. A sample was considered RV positive if rt-RT-PCR cycle threshold (Ct) was 
<35.0 32. A section of VP4/VP2 viral genomic region (~420 nucleotides long) of positive 
samples was amplified and sequenced as previously described 21. Consensus sequences 
were assembled using the Sequencher software version 5.4.6 (Gene Codes Corporation, 




















Sequence data, RV species and type assignment 
VP4/VP2 sequencing, and typing was attempted for all the RV positive samples 
collected in 2014, 2016 to 2018. For the years 2010 to 2013 and 2015, 100 RV positive 
samples were randomly selected for sequencing proportional to the monthly distribution of 
positive samples (Supplementary Table 1). Previously published VP4/VP2 sequences from 
Kilifi (January 2007– December 2009) were retrieved from GenBank (n=271, sequence 
accession numbers: KY006195 - KY006465) and combined with the 799 newly generated 
VP4/VP2 sequences (January 2010 – December 2018, GenBank sequence accession 
numbers; MW622248 - MW623046).  
 
Definition of terms 
We used the term ‘type’ to refer to RV sequences classified by either cross-
neutralization or genetic comparisons as distinct as described previously 13. Based on this 
approach, sequences were assigned into the same RV type based on >90% nucleotide 
similarity to rhinovirus prototype sequences (also referred to as reference sequences, 
http://www.picornaviridae.com/sequences/sequences.htm) and phylogenetic clustering with 
bootstrap support value >70% 13. Distributions of pairwise genetic distances were assessed 
for evaluation of intertype and intra-type divergence 13. Intra-type ‘variant’ was defined on the 
basis of a divergence threshold value determined as the least frequent value between the 
first and second modes in a pairwise nucleotide difference distribution plot. Here we are 
implicitly assuming that sequences with pairwise nucleotide difference falling into the 
distribution with the low (first) mode are members of the same phylogenetic clade, whereas 
those with pairwise nucleotide difference within the second distribution with higher mode are 
members of different phylogenetic clades. A group of viruses within the first, lower 



















The definitions used to describe the temporal occurrence of RV types are 
summarised as follows:  
a) Persistent: Continued detection, in consecutive or non-consecutive years, 
of a group of viruses belonging to the same variant of a RV type.  
b) Recurrent: Detection of a virus or group of viruses not observed in the 
preceding years (>1 year) that belong to a different variant of a previously 
observed RV type.   
c) Invasion: Detection of a new RV type not previously locally documented. 
Phylogenetic analyses 
Multiple sequence alignments (MSA) were generated using MAFFT v7.220 35 and maximum 
likelihood phylogenetic trees estimated using IQ-TREE v1.6.12 36. Branch support was 
assessed by 1000 bootstrap iterations. Temporal signal in the data was examined using 
TempEst v1.5.3 37. To infer time-scaled phylogenies, Bayesian phylogenetic analyses were 
undertaken in BEAST v.1.10.4 assuming an uncorrelated lognormal relaxed molecular 
model 38. The MCMC convergence was assessed in Tracerv1.5 and maximum clade 
credibility (MCC) trees summarized using TreeAnnotator v1.10.4 with a 10% burn-in. MCC 
trees were visualized using FigTree v1.4.4. 
Results 
RV prevalence in Kilifi, 2007 to 2018  
Between January 2007 and December 2018, a total of 7,231 NPS samples were 
collected from children (<60 months of age) admitted with severe or very severe pneumonia 
in KCH (Supplementary Table 1). RV was detected in 20.7% (1,497/7,231), with the 
proportion positive across the years ranging from 15.6% to 38.3 % (Supplementary Table 1). 



















infections were observed to occur year-round frequently peaking between the month of May 
and September each year (Figure 1). 
 
RV species and type assignment 
A total of 1,070 (71.5%) VP4/VP2 sequences (~420 nucleotides, some previously 
reported 32) were available for this analysis. Of these, 520 (48.6%) sequences were 
classified as Rhinovirus A comprising 67 distinct types; 52 (4.7%) sequences were 
Rhinovirus B comprising 18 types and 498 (46.5%) were Rhinovirus C comprising 59 types. 
Rhinovirus A and Rhinovirus C were more frequently detected while Rhinovirus B infections 
were low in number and sporadic (Figure 2(A)). The most commonly detected types were 
RV-A49 (n = 39), C2 (n = 29), C38 (n = 26), C11 (n = 26), A101 (n=24), A12 (n=23), C6 (n = 
22), C21 (n = 21), C3 (n=20) and A78 (n = 19) (Table 1). Twenty-four sequences could not 
be assigned to known RV types based on the criterion proposed by McIntyre 13 due to these 
sequences having p-distance of >10.5% with respect to their closest reference sequences 
(Supplementary Table 2). Other enteroviruses were also detected on sequencing the rt-RT-
PCR rhinovirus detections: enterovirus D68 (EV-D68) (n=5), coxsackievirus-B3 (CVB3) 
(n=1), coxsackievirus-B2 (CVB2) (n=1) and echovirus19 (E19) (n=1).  
Temporal trends of RV types in Kilifi  
We detected on average, 39 RV types annually (range, 35 - 47), a mean of eight 
(range, 1- 29) of which were new RV types identified for the first time in the population each 
year from 2008 as others previously detected types disappeared (Figure 2(B)). The 
cumulative number of new RV types detected annually increased rapidly since the beginning 
of the surveillance period and then saturated after approximately nine years (Figure 2(B)). 
RV types commonly co-circulated and with varying frequency in the 12-year period (Figure 
2(C), Supplementary File 1). Several types were present at high prevalence while others 



















RV-A56 was detected in 7 consecutive months (May to November 2007), RV-C11 was 
present for 6 consecutive months (February to July 2016), and RV-C38, A40 and C2 types 
circulated consecutively for 5 months (November 2009 to March 2010, April to August 2016 
and May to September 2010, respectively) (Supplementary File 1).  
Additionally, several types recurred after considerable periods of absence. For 
example, RV-A12 first seen in February 2007 was not detected again until February 2009, 
23 months later, while C38 viruses were detected 4 years apart between 2012 and 2016 
(Figure 3, Supplementary File 1). Temporally, several RV types exhibited synchronized co-
circulation and recurrence, for example (i) RV-C1, C11, C2, C38, C22 and C21; (ii) RV-A75, 
A89, A12, A28, A96, A106, A80 and A10; (iii) RV-A90, A55, A61, A45, A54 and A60; (iv) RV-
C14, C41, C45, C10, C16, C25, C32 and C47.  
 
Genetic diversity of RV types in Kilifi  
The nucleotide (nt) sequence identity among Rhinovirus A, Rhinovirus B and 
Rhinovirus C viruses was determined as 57.3–100%, 66.0–100%, and 45.1–100%, 
respectively, and 59.8–100%, 79.9–100% and 53.3–100% at the amino acid (aa) level, 
respectively. Intra-type nucleotide variation was observed in the VP4/VP2 region of viruses 
sampled over the 12 years study period (Figure 4(A), Supplementary Figure 1). 
Nonetheless, the substitutions were mostly synonymous i.e., not amino acid changing. The 
distribution of pairwise nucleotide distances showed multi-modal peaks suggesting 
circulation of distinct variants within individual RV types (Figure 4(B), Supplementary Figure 
2). These observations were congruent with multiple within-type phylogenetic clusters.  
Several RV types were characterised by genetically distinct temporal clusters, for 
example, RV-A49, C38 and A101 (Figure 5). RV-A49 was detected as eleven distinct 
variants circulating at different periods, three of which occurred as singletons (single 



















variants of type RV-C6 co-circulated during 2010/ 2011 (Supplementary Figure 3, Table 2), 
which likely indicates separate virus introductions into the Kilifi population. Several RV types 
had variants that contained sequences from multiple years indicating variant persistence 
over an extended period or repeated reintroductions, e.g., RV-A101 variant 5 (v5) comprised 
of viruses observed from 2010 to 2013 (Figure 5, Table 2). 
  
Discussion 
We describe the long-term pattern of co-circulation, persistence and invasion of 
rhinovirus types in hospitalized children (less than 60 months old) with pneumonia in Kilifi 
coastal Kenya over a 12-year period (2007 to 2018). Consistent with other studies, RV was 
ubiquitous and multiple types co-circulated even within a single month 16,20,21. Among the RV 
cases detected, Rhinovirus B was least frequently detected. It is not clear why Rhinovirus B 
is less diverse and each type within it was on aver ge less frequent. The observed annual 
proportions of RV species in Kilifi are consistent with recent similar epidemiological studies 
in Brazil, Nigeria and Cameroon 39–41. Although children under five years of age are not a 
comprehensive representative of the community, this demographic gives insight into the 
pattern of RV transmission since RV burden is highest in children under 5 years [14]. 
Rhinovirus detection rates decrease with increasing age as adults have had multiple and 
widespread exposures to rhinovirus types 14. Other social groups are vital in RV transmission 
30,42,43 and it would be useful to evaluate rhinovirus transmission patterns and prevalence 
within these groups.  
The majority (99%) of our sequences were within the proposed divergence 
thresholds for RV typing and classification using VP4/VP2 region (10.5% for Rhinovirus A, 
9.5% for Rhinovirus B, and 10.5% for Rhinovirus C) 13. This exemplifies significant sequence 
conservation in the VP4/VP2 region within a type allowing robust genotypic assignment. 



















whole genome sequencing to check for variation in the VP1 region and determine if they 
correspond to new types 13. Detection of other enteroviruses (EVs) reflects PCR cross-
reactivity due to nucleotide conservation at the 5'-untranslated target region 44,45. EV-D68, 
CVB3, CVB2 and E19 have been associated with respiratory disease or detected in 
respiratory samples 46,47. 
The frequent invasions of new types could be explained by lack of pre-existing 
immune memory or weak heterotypic immunity 48. The number of new types decreased over 
time, levelling off in 2016, perhaps indicating the period a population takes to experience the 
maximum number of RV types. Recurrence of RV types could be promoted by antigenic 
variation on the other surface proteins (VP2, VP1 and VP3) allowing infection where prior 
exposure confers incomplete or short-lived immunity to future genetic variants. Recurrence, 
particularly where the recurring strains were genetically identical to older strains, may also 
be observed in a population not previously exposed to a RV type. Some RV types occurred 
sporadically and could be associated with mild disease or asymptomatic infections or have 
reduced transmission rates probably suppressed by pre-existing immunity 49.  
For some RV types, the sequenced VP4/VP2 region remained conserved after 
periods of quiescence, which probably ensures strain survival by maintaining low-level 
genetic variation. In a linear strain space, strains interact via cross-immunity to nearby 
strains with shared epitopes and this interaction tails off with genetic distance 50. Yet, the 
VP4/VP2 region might not be primarily antigenic 51, and genetic changes could have 
occurred at immunogenic sites located in other capsid proteins (VP1 or VP3). Genome-wide 
sequence data would therefore be useful to confirm strain conservation and maintenance. 
The evident intra-type genetic diversity with differential temporal distribution could suggest 
sequential virus introductions or diversification of locally circulating variants 52.  
This study had two limitations. First, in some years (2010 to 2013 and 2015) we only 



















underestimate the circulating rhinovirus diversity. Samples selected were prioritised based 
on viral load and monthly distribution. Second, we only sequenced the VP4/VP2 coding 
region, but more reliable phylogenetic relationships would be defined from full-length 
genome analysis 53. 
In conclusion, this study describes the nature of RV infections in hospitalized children 
less than 60 months old and enhances our understanding on rhinovirus transmission 
dynamics in a community. Rhinovirus dynamics in Kilifi during 2007-2018 were characterised 
by repeated invasions by heterogeneous types rather than long-term continuity of the same 
RV types and continuous diversification of circulating variants. Improved understanding on 
the RV types circulating in a community may support better guidance of future therapeutic 
interventions in clinical practice. The high diversity and rates of invasion of RV as observed 
in this study, even within a short duration (week or month), underpins the application of 
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Figure 1 Monthly distribution of rhinovirus cases identified from surveillance of acute 
respiratory illness (ARIs) in children less than 60 months admitted to the Kilifi County 
Hospital, Kenya, 2007–2018.  Also included on the secondary y-axis are the proportion (% 
positivity) of the samples from the in patients with ARI that were RV positive. 
   
Figure 2 (A) Annual proportion of rhinovirus species across the 12-years period. (B) The 
total number (blue bars) and new number (purple bars) of RV types detected annually over 
the period 2007-2018. Also shown is the cumulative number of all the different RV types 
observed during the study period (black line). (C) The overall frequency of detection in 
months or the number of months each RV type was detected. The types are ordered 
alphabetically. 
 
Figure 3 Quarterly proportions of RV types detected organised at the species level; shown 
here are the temporal trends of 5 most prevalent types per species while the rest are 
indicated as others. A) Quarterly proportion of RV A types (B) Quarterly proportion of RV B 
types, (C) Quarterly proportion of RV C types.  
 
Figure 4 (A) Nucleotide variability across the sequenced VP4/VP2 region for types RV-A49 
and RV-C2. For each type, the viruses were compared to the earliest sampled sequence. 
Vertical coloured bars show the nucleotide differences: red is a change to T, orange is a 
change to A, purple is a change to C and blue is a change to G. (B) Distribution of pairwise 



















Figure 5 Bayesian phylogenetic trees showing the VP4/VP2 region of the RV types A49, C2, 
C38 and C11.Variant names are next to the phylogenetic clusters, e.g., v1 representing 
variant 1 for a specific type. Node support is indicated by (*) for posterior probabilities > 0.9. 
 
Tables 
Table 1 Number of different rhinovirus types identified in Kilifi, Kenya, 2007 -2018.  
Table 2 Number of variants for the ten most prevalent RV types identified in Kilifi, Kenya, 
2007 to 2018; * where b in a, b are the singletons (single sequence which genetically distinct 






















Table 1 Number of different  rhinovirus types identified in Kilifi, Kenya, 2007 -2018. 
RV-A                               
A49 A101 A12 A78 A56 A89 A20 A28 A40 A54 A1 A22 A61 A80 A29 A30 
39 24 23 19 18 18 17 16 16 14 13 13 13 12 11 10 
A58 A63 A82 A21 A75 A10 A47 A65 A106 A68 A103 A15 A43 A81 A88 A9 
10 10 10 9 9 8 8 8 7 7 6 6 6 6 6 6 
A16 A31 A46 A60 A66 A73 A104 A105 A13 A34 A36 A45 A55 A7 A90 A19 
5 5 5 5 5 5 4 4 4 4 4 4 4 4 4 3 
A24 A32 A38 A39 A53 A8 A94 A96 A100 A102 A11 A23 A67 A18 A33 A41 
3 3 3 3 3 3 3 3 2 2 2 2 2 1 1 1 
A51 A59 A- untyped                           
1 1 13                           
RV-B                               
B4 B70 B27 B42 B48 B86 B91 B104 B69 B102 B35 B72 B83 B101 B26 B6 
7 5 4 4 4 4 4 3 3 2 2 2 2 1 1 1 
B84 B92 B97                           




















RV-C                               
C2 C38 C11 C43 C6 C21 C3 C10 C1 C14 C22 C40 C5 C27 C36 C25 
29 26 26 26 22 21 20 18 17 16 16 16 16 15 13 12 
C45 C37 C31 C32 C9 Cpat19 C46 Cpat18 C12 C16 C55 C15 C19 C41 C51 Cpat14 
12 11 10 10 10 9 8 8 7 7 6 5 5 5 5 5 
Cpat21 C42 Cpat20 C23 C33 C35 C39 C7 C8 C26 C44 C47 C49 Cpat17 Cpat22 Cpat28 
5 4 4 3 3 3 3 3 3 2 2 2 2 2 2 2 
C13 C17 C18 C24 C29 C30 C34 C48 C50 Cpat16 Cpat27 C-untyped         




























Number of variants, 
singletons 
Period (Year)  
A12 23 9,5 v1(2007), v2(2007), v3(2009), v4(2009-2011), v5(2014), v6(2014), 
v7(2016), v8(2016), v9(2017) 
A78 19 7,3 v1(2008), v2(2010-2011), v3(2011), v4(2013), v5(2013), v6(2018), 
v7(2018) 
C2 29 12,5 v1(2007-2008), v2(2008), v3(2008), v4(2009), v5(2009), v6(2010), 
v7(2010), v8(2012), v9(2013), v10(2015), v11(2016-2017), 
v12(2017) 
C11 25 8,3 v1(2007), v2(2008), v3(2008), v4(2008), v5(2009), v6(2010-2011), 
v7(2013), v8(2016) 
C21 21 6,2 v1(2007), v2(2007-2012), v3(2010), v4(2012), v5(2015), v6(2018) 
C38 26 6,0 v1(2007), v2(2007), v3(2007), v4(2009-2011), v5(2012) , v6(2016) 





















A49 39 11,4 v1(2008), v2(2008), v3(2008-2010), v4(2009), v5(2010-2011), 
v6(2012), v7(2012), v8(2014), v9(2015), v10(2014-2015), 
v11(2013-2014,2017) 
A101 25 9,5 v1(2007), v2(2008), v3(2010), v4(2010), v5(2010-2013), v6(2015), 
v7(2013-2015), v8(2017), v9(2018) 
C6 22 11,4 v1(2007), v2(2010 - 2011), v3(2010), v4(2010), v5(2010), 
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